| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 03/21/2007 | CN1931176A Aescin medicine composition and its prepn process and use |
| 03/21/2007 | CN1931174A Aspirin buccal tablet and its prepn process |
| 03/21/2007 | CN1931139A Freeze dried ligustrazine hydrochloride prepn for injection and its prepn process |
| 03/21/2007 | CN1931131A Oil-in-water type nanometer peonol emulsion oral liquid and its prepn process |
| 03/21/2007 | CN1306020C Polyporus frondosus oral liquor and its production method |
| 03/21/2007 | CN1305871C Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2a receptor-related disorders |
| 03/21/2007 | CN1305862C 7-amino-benzothiazole derivatives as adenosine receptor ligands |
| 03/21/2007 | CN1305839C Phenylglycine derivatives |
| 03/20/2007 | US7193064 antibody or a functional fragment thereof that recognizes a human CD40 antigen present on the surface of human B cells, dendritic cells |
| 03/20/2007 | US7192964 4-oxoimidazolidine-2-spiropiperidine derivatives |
| 03/20/2007 | US7192963 Janus Kinase 3 inhibitors; organ transplant rejection, xeno transplation, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, Crohn's disease, Alzheimer's disease, leukemia, and autoimmune diseases |
| 03/20/2007 | US7192960 Sodium channel blockers |
| 03/20/2007 | US7192959 Sodium channel blockers |
| 03/20/2007 | US7192958 Antihistamines; bronchodilators; antiinflammatory agents; inflammatory bowel disorders |
| 03/20/2007 | US7192956 Inducing contraception by delivering to a female of child-bearing age a selective estrogen receptor modulator comprising cyclothiocarbamate derivative |
| 03/20/2007 | US7192945 Benzothiazepine derivatives |
| 03/20/2007 | US7192940 Ether compounds |
| 03/20/2007 | US7192926 Synthetic blood has a high-molecular weight proteins, containing a low hydroxyproline content for preventing from gelling; prevent anaphylactic shock; genetic engineering; replacement of glutamine by glutamic acid and/or replacement of asparagine by aspartic acid |
| 03/20/2007 | US7192715 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
| 03/20/2007 | US7192616 Slow down or even inhibit cellular differentiation and/or proliferation. |
| 03/20/2007 | US7192582 Human monoclonal antibodies to FC alpha receptor (CD89) |
| 03/20/2007 | CA2180954C Inhibitors of human plasmin derived from the kunitz domains |
| 03/15/2007 | WO2007029730A1 Amino acid composition for prevention or treatment of senile anemia |
| 03/15/2007 | WO2007029712A1 Promoter for introducing gene into lymphocyte or blood cell and application thereof |
| 03/15/2007 | WO2007028456A1 Substituted pyridocarboxamides as inhibitors of plasminogen activator inhibitor 1 (pai-1) |
| 03/15/2007 | WO2006115690A3 Production of emulsions for intravenous injection of water-insoluble pharmaceutical compositions |
| 03/15/2007 | WO2006089966A3 Fxiii variants with improved properties |
| 03/15/2007 | WO2006036926B1 Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones |
| 03/15/2007 | US20070060572 e.g., 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine; mitogen-activated protein kinase inhibitor; antiinflammatory agent, autoimmune diseases |
| 03/15/2007 | US20070060571 e.g. 4-(5-(4-Chlorophenyl)-3-((nitrooxy)methyl)-3-hydropyrazolyl)benzenesulfonamide and nitric oxide donor (S-nitrosothiols, nitrites, nitrates, N-oxo-N-nitrosamines, sabstrate of nitric oxide synthase); analgesics, antiinflammatory agent, wound healing; gastrointestinal disorders; side effect reduction |
| 03/15/2007 | US20070060569 Azacycloalkyl substituted acetic acid derivatives for use as MMP inhibitors |
| 03/15/2007 | US20070059797 genetic enhancers comprising the nucleotide sequences that elevates transcription of a heterologous coding sequence in a host cell |
| 03/15/2007 | US20070059723 Diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with Secs-1 polypeptides |
| 03/15/2007 | US20070059376 Peptide conjugate |
| 03/15/2007 | US20070059290 Transcriptional regulation of target genes |
| 03/15/2007 | DE102005042583A1 Iminooxazolidin-Derivate und ihre Verwendung Iminooxazolidin derivatives and their use |
| 03/15/2007 | CA2615888A1 Substituted pyridocarboxamides as inhibitors of plasminogen activator inhibitor 1 (pai-1) |
| 03/14/2007 | EP1762574A2 Chemical modification of proteins to improve biocompatibility and bioactivity |
| 03/14/2007 | EP1762568A1 Pyrazole derivatives |
| 03/14/2007 | EP1762235A1 Orally adminstered composition for preventing neonatal hemorrhages, in a tardy form, caused by a K-vitamin deficiency |
| 03/14/2007 | EP1761510A1 Method for producing 4-(benzimidazolylmethylamino)-benzamidines |
| 03/14/2007 | EP1761274A1 Use of factor viia or factor viia equivalents for preventing or attentuating haemorrhage growth, and/or oedema generation following intracerebral haemorrhage (ich) |
| 03/14/2007 | EP1581165B1 Factor viia inhibiting compounds |
| 03/14/2007 | EP1502595B1 An injection made from ixeris sonchifolia for treatment of cardio-cerebral vascular disease and fundus diseases and method of producing thereof |
| 03/14/2007 | EP1487842B1 An optically acitve pyridine derivative and a medicament containing the same |
| 03/14/2007 | EP1337276B1 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor |
| 03/14/2007 | EP1305434B1 A human disintegrin protein |
| 03/14/2007 | EP1189623B1 Method and composition for inhibiting cardiovascular cell proliferation |
| 03/14/2007 | EP1051183B1 Peritoneal dialysis solution containing modified icodextrins |
| 03/14/2007 | CN1930182A Antithrombotic compound |
| 03/14/2007 | CN1927866A Preparation method of methyl thienotetrahydropyridinacetate |
| 03/14/2007 | CN1927346A Mailuoning injection and preparation thereof |
| 03/14/2007 | CN1927314A Decoction drug for treating blood stasis type climacteric hysteromyoma and concurrent metrorrhagia and preparing method thereof |
| 03/14/2007 | CN1927310A Biological thrombolytic and antihyperglycemic nutrient solution and method for making same |
| 03/14/2007 | CN1927288A Preparing art of cassia twig and Tuckahoe composition and use thereof |
| 03/14/2007 | CN1927275A Medicament for animals with heat clearing, diuresis, phlegm removing and detoxicating functions and preparing method thereof |
| 03/14/2007 | CN1927266A Granulocyte raised drug comprising cepharanthine |
| 03/14/2007 | CN1927262A Medicament for animals with heat clearing, dampness eliminating, and diuresis functions and preparing method thereof |
| 03/14/2007 | CN1927254A Medicament for animals with heat clearing and detoxicating, blood cooling and hemostatic functions and preparing method thereof |
| 03/14/2007 | CN1927241A Pharmaceutical composition of ligustrazine and notoginsen triterpenes |
| 03/14/2007 | CN1927204A Pharmaceutical composition of ligustrazine and carthamus tinctorius yellow color |
| 03/14/2007 | CN1927167A Clopidogrel slow, controlled release formulation |
| 03/14/2007 | CN1304839C Quality control method of infusion solution for treating obliterative thrombus disease |
| 03/14/2007 | CN1304377C Metalloproteinase inhibitors |
| 03/14/2007 | CN1304052C Medicinal compositions for application to mucosa |
| 03/14/2007 | CN1304050C Pharmaceutical composition comprising factor VII polypeptides and factor XI polypeptides |
| 03/14/2007 | CN1304049C Pharmaceutical composition comprising factor VIIa and factor XIII |
| 03/14/2007 | CN1304044C Traditional Chinese medicine composition for treating iron-deficiency anemia |
| 03/14/2007 | CN1304025C Active part of Four Drug Decoction |
| 03/14/2007 | CN1304017C Capsule for activating vital energy and promoting blood circulation |
| 03/14/2007 | CN1304005C Combinations of receptor tyrosine kinase inhibitor with a1-acidic glycoprotein binding organic compound |
| 03/14/2007 | CN1303990C Sodium ferulate oral disintegrating tablet and its preparation process |
| 03/13/2007 | US7189837 Cell surface molecule-induced macrophage activation |
| 03/13/2007 | US7189820 Antibody for use in the treatment, prevention and diagnosis of cancer, autoimmune, arthritic and graft vs. host diseases |
| 03/13/2007 | US7189758 2-Benzyl-2-hydroxy-4-methyl-4-phenylpentanoic acid (1-oxo-1,3-dihydroisobenzofuran-5-yl)amide for example; treating type II diabetes, obesity, hypertension, arteriosclerosis, or glaucoma |
| 03/13/2007 | US7189743 To inhibit thrombus formation |
| 03/13/2007 | US7189738 Substituted isoindoles and their use thereof |
| 03/13/2007 | US7189727 Guanidino compounds |
| 03/13/2007 | US7189720 Selective NPY (Y5) antagonists |
| 03/13/2007 | US7189719 Sodium channel blockers |
| 03/13/2007 | US7189707 Modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby processes in which such oxidants are a participant. The invention also relates to compounds and |
| 03/13/2007 | US7189702 Glucopyranosyloxypyrazole derivatives and medicinal use thereof |
| 03/13/2007 | US7189525 Human enzymes of the metalloprotease family |
| 03/13/2007 | US7189420 Composition comprising wenguanguo extracts, methods for preparing same and uses thereof |
| 03/13/2007 | US7189389 Pharmaceutical composition of human interferon-α2 and interferon α8 subtypes |
| 03/13/2007 | CA2398182C Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
| 03/13/2007 | CA1341522C Novel granulocyte colony stimulating factor polypeptide derivatives |
| 03/08/2007 | WO2007026966A1 Thiomorpholine compound and process for preparing the same |
| 03/08/2007 | WO2007026962A1 Phenylene derivative |
| 03/08/2007 | WO2007026772A1 Transgenic avian which has foreign gene containing sequence encoding feline-derived protein and method for production thereof |
| 03/08/2007 | WO2007026771A1 Injection for intravenous drip |
| 03/08/2007 | WO2007025949A1 Novel cycloalkane carboxamides as factor xa inhibitors |
| 03/08/2007 | WO2007025940A1 Substituted biaryls and their use as factor xa inhibitors |
| 03/08/2007 | WO2007025721A1 Combined preparation of a thiazide diuretic and a loop diuretic |
| 03/08/2007 | US20070054955 3-Pyridinyl 2,3,4-Tri-O-Acetyl-5-Thio- beta -D-Xylopyranoside for the treatment or prevention of thromboses or cardiac insufficiency; chemical synthesis; hydrophilic character and good antithrombotic activity |
| 03/08/2007 | US20070054944 Pharmaceutical compositions comprising 1-isopropyl-3-[ (4-M-toluidino-3-pyridyl) sulphonyl] -urea as active ingredient |
| 03/08/2007 | US20070054904 Phenol derivatives and their use as rotamase inhibitors |
| 03/08/2007 | US20070054364 Polypeptide variants |
| 03/08/2007 | US20070054312 Human transmembrane proteins |
| 03/08/2007 | US20070053833 Hydrating a leukemia patient; parenterally administering a dose samarium ethylenediaminetetramethylenephosphonic acid (EDTMP); and melphalan, busulfan, and/or cyclophosphamiide; anticarcinogenic, antitumor, and antantiproliferative agents; autoimmune, infectious , metabolic or genetic disorders |